Hemorrhagic cystitis — prevention (ifosfamide-induced)
- Mesna binds toxic urothelial acrolein metabolites
- Hydration/urine flow are also essential
- Mesna dosing must cover the ifosfamide exposure window
- Monitor urine/hematuria during therapy
- Mesna prevents bladder toxicity—not other ifosfamide toxicities
- Cyclophosphamide risk may also warrant mesna at high doses
Use at a glance
- Mesna binds toxic urothelial acrolein metabolites
Practical pearls
- Hydration/urine flow are also essential
- Mesna dosing must cover the ifosfamide exposure window
Monitoring / follow-up
- Monitor urine/hematuria during therapy
Other practical pearls
- Mesna prevents bladder toxicity—not other ifosfamide toxicities
- Cyclophosphamide risk may also warrant mesna at high doses
Self-check
- What should be monitored during ifosfamide bladder-toxicity prevention?
Urine/hematuria. - Does mesna prevent all ifosfamide toxicities?
No—bladder toxicity only.
Drugs used for this (1)
All clinical uses · Open Hemorrhagic cystitis — prevention (ifosfamide-induced) in the interactive console ↗